This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tharpe, J. A.
Right arrow Articles by Russell, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tharpe, J. A.
Right arrow Articles by Russell, H.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Mar 1996, 227-229, Vol 3, No. 2
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Purification and seroreactivity of pneumococcal surface adhesin A (PsaA)

JA Tharpe and H Russell
Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.

Pneumococcal surface adhesin A (PsaA) is a 37-kDa common protein antigen of Streptococcus pneumoniae. In the present study, the protein was purified so that its immunoreactivity could be determined. PsaA was released and purified from cells by lysis in the presence of n- laurylsarcosine; this was followed by ammonium sulfate precipitation and subsequent preparative isoelectric focusing. A capture antibody enzyme-linked immunosorbent assay was used to determine the immunoreactivity of purified PsaA. The assay had a 67% sensitivity for sera from patients with bacteremic pneumococcal pneumonia. A specificity of 97% was estimated on the basis of a lack of reactivity with sera from patients with pneumonia caused by other organisms. PsaA is a potential vaccine candidate and may be useful as an antigen in a diagnostic assay for pneumococcal disease.


This article has been cited by other articles:

  • Scott, J. A. G., Mlacha, Z., Nyiro, J., Njenga, S., Lewa, P., Obiero, J., Otieno, H., Sampson, J. S., Carlone, G. M. (2005). Diagnosis of Invasive Pneumococcal Disease among Children in Kenya with Enzyme-Linked Immunosorbent Assay for Immunoglobulin G Antibodies to Pneumococcal Surface Adhesin A. CVI 12: 1195-1201 [Abstract] [Full Text]  
  • Laine, C., Mwangi, T., Thompson, C. M., Obiero, J., Lipsitch, M., Scott, J. A. G. (2004). Age-Specific Immunoglobulin G (IgG) and IgA to Pneumococcal Protein Antigens in a Population in Coastal Kenya. Infect. Immun. 72: 3331-3335 [Abstract] [Full Text]  
  • Spellerberg, B., Rozdzinski, E., Martin, S., Weber-Heynemann, J., Schnitzler, N., Lutticken, R., Podbielski, A. (1999). Lmb, a Protein with Similarities to the LraI Adhesin Family, Mediates Attachment of Streptococcus agalactiae to Human Laminin. Infect. Immun. 67: 871-878 [Abstract] [Full Text]  
  • Briles, D. E., Tart, R. C., Swiatlo, E., Dillard, J. P., Smith, P., Benton, K. A., Ralph, B. A., Brooks-Walter, A., Crain, M. J., Hollingshead, S. K., McDaniel, L. S. (1998). Pneumococcal Diversity: Considerations for New Vaccine Strategies with Emphasis on Pneumococcal Surface Protein A (PspA). Clin. Microbiol. Rev. 11: 645-657 [Abstract] [Full Text]  
  • Crook, J., Tharpe, J. A., Johnson, S. E., Williams, D. B., Stinson, A. R., Facklam, R. R., Ades, E. W., Carlone, G. M., Sampson, J. S. (1998). Immunoreactivity of Five Monoclonal Antibodies against the 37-Kilodalton Common Cell Wall Protein (PsaA) of Streptococcus pneumoniae. CVI 5: 205-210 [Abstract] [Full Text]